Stabilized hemocompatible coating of nitinol devices based on photo-cross-linked alginate/heparin multilayer.
A novel stabilized hemocompatible multicomponent coating was engineered by consecutive alternating adsorption of two polysaccharides, alginate (Alg) and heparin (Hep), onto a Nitinol surface via electrostatic interaction in combination with photoreaction in situ. For this purpose, a photosensitive cross-linker, p-diazonium diphenyl amine polymer (PA), was used as an interlayer between alginate and heparin. The optical intensity of UV/vis spectra increased linearly with the number of layers, indicating the buildup of a multilayer structure and uniform coating. Photo-cross-linking resulted in higher stability without compromising its catalytic capacity to promote antithrombin III (ATIII)-mediated thrombin inactivation. Chromogenic assays for heparin activity proved definitively that anticoagulation activity really comes from surface-bound heparin in multilayer film, not from solution-phase free heparin that has leaked from multilayer film. The activated partial thromboplastin time (aPTT) assay showed that both (PA/Hep)8- and (PA/Alg/PA/Hep)4-coated Nitinol were less thrombogenic than the uncoated one. Yet, the latter was found to be more stable under a continuous shaken wash. In addition, (PA/Alg/PA/Hep)4 film exhibited lower surface roughness and higher hydrophilicity than (PA/Hep)8. As a result, hemolysis of (PA/Alg/PA/Hep)4 (0.34 +/- 0.064%) was lower than (PA/Hep)8 (0.52 +/- 0.241%). The naked Nitinol and (PA/Hep)8-coated Nitinol showed relatively strong platelet adhesion. On the contrary, no sign of any cellular matter was seen on the (PA/Alg/PA/Hep)4 surface. It is believed that the phenomenon of interlayer diffusion resulted in blended structures, hence, the enhanced wettability and antifouling properties after the incorporation of alginate layers. It is likely that the cooperative effect of alginate and heparin led to the excellent blood compatibility of the (PA/Alg/PA/Hep)4 coating. To simplify, there is greater advantage in utilizing cross-linked alginate/heparin surfaces rather than merely the heparin surface for improving blood- and tissue-compatible devices.
Liu
Meng
M
Nanobiotechnology and Biosensor Lab, Bio-X Center, Harbin Institute of Technology, Harbin, China.
Yue
Xiuli
X
Dai
Zhifei
Z
Xing
Lei
L
Ma
Fang
F
Ren
Nanqi
N
D000464:Alginates / Q000737:chemistry*; D000497:Alloys / Q000737:chemistry*; D000818:Animals; D003432:Cross-Linking Reagents / Q000737:chemistry*; D004155:Diphenhydramine / Q000737:chemistry; D020723:Glucuronic Acid / Q000737:chemistry; D006461:Hemolysis; D006493:Heparin / Q000737:chemistry* / Q000378:metabolism; D006603:Hexuronic Acids / Q000737:chemistry; D006801:Humans; D008855:Microscopy, Electron, Scanning; D015394:Molecular Structure; D010777:Photochemistry; D010973:Platelet Adhesiveness; D055672:Static Electricity; D013552:Swine; D013917:Thrombin / Q000378:metabolism; D014466:Ultraviolet Rays
D000464:Alginates; D000497:Alloys; D003432:Cross-Linking Reagents; D006603:Hexuronic Acids; C013616:nitinol; D020723:Glucuronic Acid; D004155:Diphenhydramine; D006493:Heparin; D013917:Thrombin